AU2001256435A1 - Use of lactobacillus casei in immunostimulatory compositions - Google Patents

Use of lactobacillus casei in immunostimulatory compositions

Info

Publication number
AU2001256435A1
AU2001256435A1 AU2001256435A AU2001256435A AU2001256435A1 AU 2001256435 A1 AU2001256435 A1 AU 2001256435A1 AU 2001256435 A AU2001256435 A AU 2001256435A AU 2001256435 A AU2001256435 A AU 2001256435A AU 2001256435 A1 AU2001256435 A1 AU 2001256435A1
Authority
AU
Australia
Prior art keywords
lactobacillus casei
immunostimulatory compositions
immunostimulatory
compositions
casei
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001256435A
Other versions
AU2001256435B2 (en
Inventor
Benjamin Bonavida
Eric Postaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gervais Danone SA
Original Assignee
Gervais Danone SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0006679A external-priority patent/FR2809312B1/en
Application filed by Gervais Danone SA filed Critical Gervais Danone SA
Publication of AU2001256435A1 publication Critical patent/AU2001256435A1/en
Application granted granted Critical
Publication of AU2001256435B2 publication Critical patent/AU2001256435B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001256435A 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory compositions Ceased AU2001256435B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR00/06679 2000-05-25
FR0006679A FR2809312B1 (en) 2000-05-25 2000-05-25 USE OF L. CASEI IN IMMUNOSTIMULATING COMPOSITIONS
PCT/FR2001/001310 WO2001089541A1 (en) 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory peptides

Publications (2)

Publication Number Publication Date
AU2001256435A1 true AU2001256435A1 (en) 2002-02-21
AU2001256435B2 AU2001256435B2 (en) 2006-06-29

Family

ID=8850597

Family Applications (2)

Application Number Title Priority Date Filing Date
AU5643501A Pending AU5643501A (en) 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory peptides
AU2001256435A Ceased AU2001256435B2 (en) 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU5643501A Pending AU5643501A (en) 2000-05-25 2001-04-27 Use of lactobacillus casei in immunostimulatory peptides

Country Status (28)

Country Link
US (1) US7604809B2 (en)
EP (1) EP1283714B1 (en)
JP (1) JP2003534284A (en)
CN (1) CN1194707C (en)
AR (1) AR028626A1 (en)
AT (1) ATE332143T1 (en)
AU (2) AU5643501A (en)
BG (1) BG65884B1 (en)
BR (1) BR0111135A (en)
CA (1) CA2410350C (en)
CZ (1) CZ303600B6 (en)
DE (1) DE60121327T2 (en)
DK (1) DK1283714T3 (en)
EA (1) EA005081B1 (en)
ES (1) ES2267763T3 (en)
FR (1) FR2809312B1 (en)
HK (1) HK1055898A1 (en)
HR (1) HRP20020935A2 (en)
HU (1) HUP0302041A3 (en)
IL (1) IL152980A0 (en)
MA (1) MA25760A1 (en)
MX (1) MXPA02011636A (en)
NO (1) NO332369B1 (en)
PL (1) PL201801B1 (en)
PT (1) PT1283714E (en)
SK (1) SK18272002A3 (en)
WO (1) WO2001089541A1 (en)
ZA (1) ZA200209087B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
GB0009294D0 (en) 2000-04-15 2000-05-31 Sec Dep For The Home Departmen Improvements in and relating to analysis of DNA samples
US9610347B2 (en) * 2001-04-30 2017-04-04 Cortcontrol Vaccination response for immunodeficiency or high cortisol
CN1317385C (en) * 2003-05-30 2007-05-23 上海光明乳业股份有限公司 Cheese lactobacillus Bd-II strain and use for decreasing blood fat
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
ATE361101T1 (en) * 2004-08-24 2007-05-15 Nutricia Nv FOOD COMPOSITION CONTAINING INDIGESTIBLE OLIGOSACCHARIDES
ZA200705844B (en) * 2004-12-15 2008-09-25 Van Der Westhuzen Corne Floris Detoxifying and immunity-booster composition
EP1683425A1 (en) * 2005-01-21 2006-07-26 Compagnie Gervais Danone Use of a fermented milk containing L. Casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
ES2264368B1 (en) * 2005-02-11 2007-12-01 Francisco Exposito Mesa FOOD OR DIETETIC COMPLEMENT COMPOSED BY PRODUCTS FROM THE LIST OF MICROORGANISMS.
BRPI0611492B1 (en) 2005-05-31 2021-10-13 Mars, Incorporated BIFIDOBACTERIA PROBIOTICS FELINE
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
CA2662226C (en) 2006-09-10 2020-08-04 Glycotope Gmbh Fully human high yield production system for improved antibodies and proteins
FR2912657B1 (en) * 2007-02-16 2009-04-17 Gervais Danone Sa USE OF LACTOBACILLUS CASEI TO ENHANCE PROTECTION INDUCED BY ANTI-INFLUENZA VACCINATION.
WO2009021585A1 (en) * 2007-08-13 2009-02-19 Dsm Ip Assets B.V. Probiotic bacteria for rducing the occurence of symptoms of winter infections
WO2009067000A1 (en) * 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
EP2119365B1 (en) 2008-05-13 2017-08-16 Glycotope GmbH Fermentation process
CA2722738C (en) * 2008-05-13 2017-04-25 Glycotope Gmbh Fermentation process
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2153837A1 (en) 2008-08-14 2010-02-17 Compagnie Gervais Danone Compositions comprising Lactobacillus casei for improving resistance to common infectious diseases
FR2937252B1 (en) * 2008-10-17 2011-05-20 Pf Medicament ASSOCIATION OF AN EXTRACT OF SUREAU AND A L. PARACASEI STRAIN
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
BR112012016894A2 (en) * 2010-01-08 2015-09-15 Gervais Danone Sa lactobacilli with antioxidant action.
EA031179B1 (en) * 2010-03-12 2018-11-30 Компани Жервэ Данон Lactic acid bacteria for coeliac disease
CN105288616B (en) * 2010-10-15 2018-10-19 科.汉森有限公司 immunologic adjuvant
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
US9700610B2 (en) 2011-08-22 2017-07-11 Glycotope Gmbh Microorganisms carrying a tumor antigen
WO2014038929A1 (en) 2012-09-07 2014-03-13 N.V. Nutricia Probiotics for producing antiviral factors
CA3100608A1 (en) 2018-05-18 2019-11-21 Daiichi Sankyo Co., Ltd. Anti-muc1 antibody-drug conjugate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05236872A (en) * 1992-02-27 1993-09-17 Takanashi Nyugyo Kk Food containing lactic acid bacterium
JP4112021B2 (en) * 1994-02-16 2008-07-02 明治乳業株式会社 Immunostimulant using lactic acid bacteria
WO1996020607A1 (en) * 1995-01-02 1996-07-11 Compagnie Gervais Danone Milk starter culture and use thereof for preparing antidiarrhoeal products
CN1150314C (en) * 1997-08-21 2004-05-19 纽西兰乳品局 Immunity enhancing lactic acid bacteria
US6699517B2 (en) * 1997-11-28 2004-03-02 Compagnie Gervais Danone Method for preparing food products by fermenting soy milk with streptococcus thermophilus
IT1298918B1 (en) * 1998-02-20 2000-02-07 Mendes Srl USE OF ARGININE DEIMINASE BACTERIA TO INDUCE APOPTOSIS AND / OR REDUCE AN INFLAMMATORY REACTION AND PHARMACEUTICAL COMPOSITIONS
KR100324441B1 (en) * 1999-02-08 2002-02-27 이은선 Food for preventing gastritis, gastric and duodenal ulcers

Similar Documents

Publication Publication Date Title
AU2001256435A1 (en) Use of lactobacillus casei in immunostimulatory compositions
AU5643501A (en) Use of lactobacillus casei in immunostimulatory peptides
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU5002301A (en) Cosmetic compositions comprising exfoliating enzymes and uses thereof
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU2001234437A1 (en) Deicing compositions and methods of use
AU2001229593A1 (en) Mineral water composition containing bifidobacterium probiotic agent
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
WO2002036145A3 (en) Kahalalide f formulation
AU2001276461A1 (en) Cleaning compositions and their use
AU7364700A (en) Use of psychrotrophic bacterium in biotechnology applications
AU2001261317A1 (en) Immunostimulant compositions and associated methods
HUP0303936A3 (en) Novel composition and use
AU2001297556A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
PL362753A1 (en) New strain of lactobacillus paracasei
AU2001238091A1 (en) Tgf-beta therapeutics, compositions and methods of use
AUPQ760400A0 (en) Herbical formulations and methods of use thereof
AU2001239954A1 (en) Cleaning compositions and use thereof
AU3002901A (en) Bacterial galactanases and use thereof
AU2001242019A1 (en) Compositions and methods for use thereof in modifying the genomes of microorganisms
AU2001236001A1 (en) Immune enhancement compositions and use thereof
AU4304700A (en) Immunostimulatory pharmaceutical composition and its use protocol
AU2001231141A1 (en) Novel human septin and uses thereof
AU2001297794A1 (en) Methods and compositions of human proteins and uses thereof.